Business
Why the Race Oncology (ASX:RAC) share price is rocketing 10% higher
The Race Oncology Ltd (ASX: RAC) share price has been a very strong performer on Thursday.
In morning trade, the precision oncology company’s shares are up 10% to $3.38.
Why is the Race Oncology share price storming higher?
Investors have been buying the company’s shares following the release of a positive announcement this morning.
That announcement revealed details of a recent scientific publication in the prestigious journal Nature Communication.
According to the release, the publication confirms that its phase 2/3 cancer drug Bisantrene is a highly effective inhibitor of the Fat Mass and Obesity associated protein (FTO).
The release notes that the independent work was performed by a research team at the University of…
-
General16 hours agoAs Iran-Australia relations plunge to a new low, Tehran faces another diplomatic setback
-
General23 hours agoPolice offer ‘surrender plan’ to Dezi Freeman as fugitive avoids capture for another day
-
General22 hours agoScientists discover ‘jaw-droppingly weird’ dinosaur fossil in Morocco
-
General21 hours agoGeelong Cats AFL star Bailey Smith details mental health battle during All-Australian speech